Mikkel Østergaard Selected Research

Tenosynovitis

10/2017	Magnetic resonance imaging assessed inflammation in the wrist is associated with patient-reported physical impairment, global assessment of disease activity and pain in early rheumatoid arthritis: longitudinal results from two randomised controlled trials.
1/2017	Intramuscular versus ultrasound-guided intratenosynovial glucocorticoid injection for tenosynovitis in patients with rheumatoid arthritis: a randomised, double-blind, controlled study.
5/2015	Aiming for a simpler early arthritis MRI protocol: can Gd contrast administration be eliminated?
5/2015	A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mikkel Østergaard Research Topics

Disease

75	Rheumatoid Arthritis 07/2022 - 06/2003
33	Inflammation (Inflammations) 11/2022 - 01/2009
27	Synovitis 01/2022 - 06/2003
25	Axial Spondyloarthritis 11/2022 - 08/2011
19	Ankylosing Spondylitis 01/2022 - 04/2007
11	Pain (Aches) 01/2022 - 01/2009
10	Psoriatic Arthritis 11/2022 - 02/2011
7	Edema (Dropsy) 01/2022 - 06/2003
7	Arthritis (Polyarthritis) 01/2021 - 08/2011
6	Necrosis 11/2021 - 08/2011
6	Infections 01/2021 - 03/2016
6	Osteitis 01/2020 - 11/2011
6	Rheumatic Diseases (Rheumatism) 01/2018 - 01/2010
4	Gout 11/2022 - 09/2018
4	Back Pain (Backache) 01/2022 - 10/2010
4	Fatigue 01/2022 - 01/2015
4	Tenosynovitis 10/2017 - 05/2015
3	Non-Radiographic Axial Spondyloarthritis 01/2022 - 01/2017
3	Joint Diseases (Joint Disease) 01/2021 - 02/2014
2	Ankylosis 01/2022 - 03/2020
2	Sacroiliitis 01/2020 - 01/2020
2	Neoplasms (Cancer) 01/2020 - 01/2019
2	Body Weight (Weight, Body) 09/2017 - 05/2006
1	Human Influenza (Influenza) 10/2022
1	Spondylitis 04/2022
1	Metaplasia 01/2022
1	Pelvic Pain 01/2022
1	Chronic Disease (Chronic Diseases) 01/2022

Drug/Important Bio-Agent (IBA)

20	Biological ProductsIBA 11/2022 - 09/2007
17	Adalimumab (Humira)FDA Link 11/2022 - 08/2006
17	C-Reactive ProteinIBA 11/2022 - 04/2004
15	Methotrexate (Mexate)FDA LinkGeneric 03/2021 - 05/2006
14	Biomarkers (Surrogate Marker)IBA 01/2022 - 08/2011
14	Antirheumatic Agents (DMARD)IBA 11/2021 - 08/2009
12	Tumor Necrosis Factor InhibitorsIBA 11/2022 - 12/2014
9	Abatacept (Orencia)FDA Link 11/2022 - 01/2016
9	Pharmaceutical PreparationsIBA 01/2022 - 01/2010
8	Rheumatoid FactorIBA 12/2020 - 01/2011
7	Anti-Citrullinated Protein AntibodiesIBA 12/2020 - 04/2009
7	Monoclonal AntibodiesIBA 03/2020 - 08/2010
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2014 - 09/2007
5	secukinumabIBA 01/2022 - 01/2020
5	ametantrone (HAQ)IBA 01/2022 - 10/2009
5	golimumab FDA Link 11/2020 - 11/2011
4	Uric Acid (Urate)IBA 11/2022 - 09/2018
4	AutoantibodiesIBA 01/2021 - 10/2014
4	Betamethasone (Celestone)FDA Link 01/2017 - 05/2006
3	ixekizumabIBA 11/2022 - 01/2020
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2022 - 04/2016
3	Interleukin-17 (Interleukin 17)IBA 01/2022 - 01/2020
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 08/2011
3	Rituximab (Mabthera)FDA Link 01/2020 - 01/2016
3	Infliximab (Remicade)FDA Link 12/2019 - 09/2007
3	ofatumumab FDA Link 01/2016 - 08/2010
3	cyclic citrullinated peptideIBA 08/2014 - 04/2009
3	Immunoglobulin M (IgM)IBA 08/2014 - 08/2011
3	Cartilage Oligomeric Matrix ProteinIBA 12/2011 - 08/2011
2	GLPG0634IBA 01/2022 - 01/2022
2	LipidsIBA 03/2021 - 09/2017
2	Biosimilar PharmaceuticalsIBA 03/2020 - 12/2019
2	tocilizumab (atlizumab)FDA Link 01/2020 - 01/2019
2	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2020 - 04/2016
2	GlucocorticoidsIBA 01/2017 - 01/2017
2	ORALIT (ORS)IBA 04/2016 - 01/2010
2	Etanercept (Enbrel)FDA Link 01/2016 - 01/2010
2	Triamcinolone (Aristocort)FDA Link 05/2015 - 04/2014
2	GadoliniumIBA 05/2015 - 06/2003
2	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 12/2011 - 08/2011
2	Interleukin-6 (Interleukin 6)IBA 12/2011 - 08/2011
2	OsteocalcinIBA 12/2011 - 08/2011
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2011 - 08/2011
2	Aggrecans (Aggrecan)IBA 12/2011 - 08/2011
2	Collagen Type II (Type II Collagen)IBA 12/2011 - 08/2011
2	Fenofibrate (CiL)FDA LinkGeneric 07/2011 - 01/2009
2	Proteins (Proteins, Gene)FDA Link 01/2011 - 01/2009
2	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 12/2010 - 10/2010
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 10/2010 - 05/2006
1	COVID-19 VaccinesIBA 10/2022
1	ChemokinesIBA 07/2022
1	catch-relaxing peptide (Mytilus)IBA 01/2022
1	Extracellular Matrix ProteinsIBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	CollagenIBA 01/2022
1	LDL CholesterolIBA 03/2021
1	Interferon-alpha (Interferon Alfa)IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	Carbon MonoxideIBA 12/2020
1	CalciumIBA 11/2020
1	CholesterolIBA 11/2020
1	Glucose (Dextrose)FDA LinkGeneric 11/2020
1	Triglycerides (Triacylglycerol)IBA 11/2020

Therapy/Procedure

27	Therapeutics 11/2022 - 05/2006
4	Aftercare (After-Treatment) 11/2021 - 04/2007
3	Drug Tapering 01/2021 - 01/2016
3	Biological Therapy 01/2019 - 09/2013
2	Injections 05/2015 - 06/2012
2	Intra-Articular Injections 06/2012 - 10/2010
1	Nicotine Replacement Therapy 12/2020